| Igama | I-Orlistat |
| Inombolo yeCAS | 96829-58-2 |
| Ifomula yemolekyuli | C29H53NO5 |
| Ubunzima bemolekyuli | 495.73 |
| Inombolo ye-EINECS | 639-755-1 |
| Indawo yokunyibilika | <50°C |
| Ukuxinana | 0.976±0.06g/cm3(Kuxelwe kwangaphambili) |
| Imeko yokugcina | 2-8°C |
| Ifom | Umgubo |
| Umbala | Mhlophe |
| I-acidity coefficient | (pKa) 14.59±0.23 (Kuxelwe kwangaphambili) |
(S) -2-FORMYLAMINO-4-METHYL-PENTANOICACID(S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL]METHYL]-DODECYLESTER;RO-18-0647;(-)-TETRAHYDROLIPSTAN; I-ORMYL-L-LEUCINE(1S)-1-[[(2S,3S)-3-HEXYL-4-OXO-2-OXETANYL]METHYL]DODECYLESTER;Orlistat(synthetase/compound);Orlistat(synthesis);Orlistat(FerMentation)
Iipropati
Umgubo omhlophe wekristale, phantse awunyibiliki emanzini, unyibilika ngokulula kwiklorofomu, unyibilika ngokugqithisileyo kwi-methanol kunye ne-ethanol, kulula ukuyi-pyrolyze, indawo yokunyibilika yi-40℃~42℃. I-molecule yayo yi-diastereomer equkethe amaziko amane e-chiral, kubude be-wavelength ye-529nm, isisombululo sayo se-ethanol sinokujikeleza okungahambi kakuhle.
Indlela yokwenza
I-Orlistat yinto esebenza ixesha elide kunye neyona nto inamandla ye-gastrointestinal lipase inhibitor, eyenza i-enzymes ezimbini ezingentla apha ngokwenza i-covalent bond kunye ne-serine site esebenzayo ye-lipase esiswini kunye namathumbu amancinci. I-enzymes engasebenziyo ayikwazi ukuqhekeza amanqatha ekudleni kwi-fatty acids yamahhala kunye ne-Chemicalbook glycerol enokuthi ifakwe ngumzimba, ngaloo ndlela inciphisa ukutya kunye nokunciphisa ubunzima. Ukongeza, ezinye izifundo zifumene ukuba i-orlistat inqanda ukufunxwa kwamathumbu emathunjini e-cholesterol ngokuthintela i-niemann-pick C1-like protein 1 (niemann-pickC1-like1, NPC1L1).
Iimpawu
Le mveliso ngokudibanisa nokutya okuncinci kwe-hypocaloric kuboniswa kunyango lwexesha elide labantu abatyebileyo nabatyebileyo, kubandakanywa nabo banemingcipheko emiselweyo ehambelana nokukhuluphala. Le mveliso inokulawula ubunzima bexesha elide (ukulahleka kwesisindo, ukugcinwa kwesisindo kunye nokuthintela ukuphindaphinda) ukusebenza kakuhle. Ukuthatha i-orlistat kunokunciphisa imingcipheko enxulumene nokukhuluphala kunye neziganeko zezinye izifo ezinxulumene nokukhuluphala, kubandakanywa ne-hypercholesterolemia, uhlobo lwe-2 yeswekile, ukunyamezela kwe-glucose, i-hyperinsulinemia, i-hypertension, kunye nomxholo we-fat content.
Ukunxibelelana kwezamayeza
Inokunciphisa ukuxutywa kwamavithamini A, D kunye no-E. Inokuxhaswa kunye nale mveliso ngexesha elifanayo. Ukuba uthatha amalungiselelo aqukethe iivithamini A, D kunye ne-E (ezifana nezinye i-multivitamins), kufuneka uthathe le mveliso kwiiyure ezingama-2 emva kokuthatha le mveliso okanye ngexesha lokulala. Abantu abanesifo sikashukela sohlobo lwe-2 banokufuna ukunciphisa umthamo we-oral hypoglycemic agents (umzekelo, i-sulfonylureas). Ukusetyenziswa ngokubambisana kunye ne-cyclosporine kunokubangela ukuhla kwe-plasma concentrations yokugqibela. Ukusetyenziswa kunye ne-amiodarone kunokubangela ukunciphisa ukufunxa kokugqibela kunye nokunciphisa ukusebenza kakuhle.